Research Analysts’ Recent Ratings Updates for Tenet Healthcare (THC)

Tenet Healthcare (NYSE: THC) has recently received a number of price target changes and ratings updates:

• 5/11/2026 – Tenet Healthcare was downgraded by Wall Street Zen from “strong-buy” to “buy”.
• 5/5/2026 – Tenet Healthcare had its price target lowered by Barclays PLC from $257.00 to $238.00. They now have an “overweight” rating on the stock.
• 5/5/2026 – Tenet Healthcare had its price target lowered by Robert W. Baird from $245.00 to $210.00. They now have a “neutral” rating on the stock.
• 5/4/2026 – Tenet Healthcare had its price target lowered by Stephens from $275.00 to $260.00. They now have an “overweight” rating on the stock.
• 5/3/2026 – Tenet Healthcare was upgraded by Wall Street Zen from “buy” to “strong-buy”.
• 5/1/2026 – Tenet Healthcare was given a new $254.00 price target by Morgan Stanley.
• 5/1/2026 – Tenet Healthcare had its price target lowered by Royal Bank Of Canada from $277.00 to $236.00. They now have an “outperform” rating on the stock.
• 5/1/2026 – Tenet Healthcare had its price target lowered by Guggenheim from $283.00 to $252.00. They now have a “buy” rating on the stock.
• 5/1/2026 – Tenet Healthcare had its price target lowered by Wells Fargo & Company from $265.00 to $213.00. They now have an “overweight” rating on the stock.
• 5/1/2026 – Tenet Healthcare had its price target lowered by KeyCorp from $250.00 to $225.00. They now have an “overweight” rating on the stock.
• 4/25/2026 – Tenet Healthcare was downgraded by Wall Street Zen from “strong-buy” to “buy”.
• 3/27/2026 – Tenet Healthcare had its “buy (b-)” rating reaffirmed by Weiss Ratings.
• 3/12/2026 – Tenet Healthcare had its price target raised by Guggenheim from $271.00 to $283.00. They now have a “buy” rating on the stock.
• 3/12/2026 – Tenet Healthcare had its price target raised by Mizuho from $235.00 to $265.00. They now have an “outperform” rating on the stock.

Insider Buying and Selling

In related news, EVP Paola M. Arbour sold 6,500 shares of the company’s stock in a transaction that occurred on Wednesday, March 11th. The shares were sold at an average price of $238.43, for a total transaction of $1,549,795.00. Following the sale, the executive vice president directly owned 29,291 shares of the company’s stock, valued at $6,983,853.13. This represents a 18.16% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider R. Scott Ramsey sold 8,017 shares of the company’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $232.70, for a total transaction of $1,865,555.90. The SEC filing for this sale provides additional information. Insiders have sold a total of 46,517 shares of company stock valued at $10,943,111 in the last ninety days. Company insiders own 0.81% of the company’s stock.

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.